Stodgy order
5 March 2020

The $36 bln cafeteria supplier is eyeing European wholesaler Metro. It’s an odd move for new CEO Kevin Hourican, who led CVS’ pharmacy roll-out. Europe’s weak growth and profitability mean he would need a bargain to make the deal work. And the target’s noisy owners won’t help.